💰NIH Notice on Closed Meeting for Grant Application Review
The Department of Health and Human Services announces a closed meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel to evaluate grant applications. The meeting aims to review applications that may disclose sensitive trade secrets and personal information, ensuring confidentiality for participants involved in the grant process.
Learn More💰National Cancer Institute Grant Opportunities Announcement – April 2025
The Department of Health and Human Services announces a closed meeting by the National Cancer Institute to review grant applications related to cancer research. The notice emphasizes the confidentiality of discussions and outlines meeting details, including date, time, and location, highlighting the importance of privacy in grant evaluations.
Learn More🏥Notice of NIH Grant Review Meetings for Health Research Grants
The Department of Health and Human Services announces closed meetings of the National Heart, Lung, and Blood Institute focused on reviewing grant applications related to cardiovascular disease and health research. These virtual meetings provide a platform for evaluating proposals that may connect with significant health initiatives.
Learn More🩺National Cancer Institute’s Closed Meetings on Grant Applications
The National Cancer Institute announces closed meetings for the evaluation of grant applications related to physical sciences oncology. These meetings will assess research projects and may involve confidential discussions around trade secrets and personal privacy, taking place virtually at the National Cancer Institute's facility in Maryland.
Learn More🎓NIH Announces Closed Meetings for Grant Application Reviews
The National Institute of General Medical Sciences has announced closed meetings to review grant applications for research excellence programs, including the SuRE and SBIR/STTR initiatives. These meetings, which are closed to the public due to confidentiality concerns, are essential for assessing funding opportunities that support biomedical research and innovation.
Learn More💼Notice of NIH Grant Review Meeting by Heart, Lung, and Blood Institute
The National Heart, Lung, and Blood Institute announces a closed meeting to review grant applications. The meeting, scheduled for April 22, 2025, will evaluate confidential trade secrets and personal information, ensuring privacy during discussions on significant health research funding. Contact details are provided for further inquiries.
Learn More💼Notice of Grant Review Meeting by National Institute of Allergy and Infectious Diseases
The Department of Health and Human Services announces a closed meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel to evaluate grant applications. The session, which includes discussions on confidential trade secrets and individual privacy, will be conducted via video assistance.
Learn More💊National Institute on Drug Abuse
The National Institute on Drug Abuse announces closed meetings to review grant applications related to drug abuse research. These meetings focus on evaluating various research proposals and initiatives, including medication development and chemical countermeasures for opioid exposure. The discussions aim to advance scientific research and innovation in drug-related fields.
Learn More🏥National Cancer Institute Notice on Grant Review Meetings
The National Cancer Institute announces closed meetings to review grant applications related to diet, lipid metabolism, and cancer. These meetings are in compliance with federal law and focus on evaluating grant applications, likely affecting confidential trade secrets and personal privacy issues within the field.
Learn More💊FDA Withdraws Approval of Abbreviated New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of four abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Learn More